These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8560121)

  • 1. [Pharmacokinetic implications associated to the use of drugs as racemates or pure enantiomers].
    Speisky H; Squella JA; Nuñez-Vergara LJ
    Rev Med Chil; 1995 Jul; 123(7):884-91. PubMed ID: 8560121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of physiologically based models to simulate enantioselective differences in pharmacokinetics.
    Piotrovskij VK; Shvatchko EV; Trnovec T
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):263-9. PubMed ID: 8051986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential properties of enantiomers of commercially available racemates.
    Gulati V
    J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomers: implications and complications in developmental pharmacology.
    Eichelbaum M
    Dev Pharmacol Ther; 1992; 18(3-4):131-4. PubMed ID: 1306801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chiral switch: pure enantiomers of drugs instead of racemic mixtures].
    Valentová J; Hutt AJ
    Ceska Slov Farm; 2004 Nov; 53(6):285-93. PubMed ID: 15630994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.
    Brocks DR
    Biopharm Drug Dispos; 2006 Nov; 27(8):387-406. PubMed ID: 16944450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single enantiomer drugs: should they be developed?
    Khan AY; Preskorn SH; Wimalasena K
    Essent Psychopharmacol; 2006; 7(1):15-23. PubMed ID: 16989289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselectivity in drug metabolism.
    Lu H
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probenecid-induced changes in the clearance of pranoprofen enantiomers.
    Imai T; Nomura T; Otagiri M
    Chirality; 2003 May; 15(4):318-23. PubMed ID: 12666238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racemic mixtures: harmless or potentially toxic?
    Ehrlich GE
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S15-8. PubMed ID: 1530003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chirality and its implications in transdermal drug development.
    Reddy IK; Kommuru TR; Zaghloul AA; Khan MA
    Crit Rev Ther Drug Carrier Syst; 2000; 17(4):285-325. PubMed ID: 10958245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stereochemistry--an overlooked problem in medical treatment and research].
    Mikkelsen EO
    Ugeskr Laeger; 1990 Jul; 152(28):2029-32. PubMed ID: 2195737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate.
    Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G
    Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of chirality in clinical pharmacology].
    Le Corre P; Sado P; Le Verge R
    J Pharm Belg; 1991; 46(5):331-47. PubMed ID: 1791526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of chiral drugs].
    Bernareggi A
    Boll Chim Farm; 1995 Feb; 134(2):63-8. PubMed ID: 7598834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
    Główka FK; Caldwell J
    Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chiral compounds and their pharmacologic effects].
    Slováková A; Hutt AJ
    Ceska Slov Farm; 1999 May; 48(3):107-12. PubMed ID: 10422348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chirality and pharmacokinetics: an area of neglected dimensionality?
    Hutt AJ
    Drug Metabol Drug Interact; 2007; 22(2-3):79-112. PubMed ID: 17708062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
    Aboul-Enein HY; El-Awady MI; Heard CM; Nicholls PJ
    Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.